The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

Packsize®, the market leader in sustainable, right-sized, on-demand packaging, announced today a new partnership with Henkel Adhesive Technologies to enhance the Company's sustainable product ...

COVID-19 vaccine DNA contamination claims aren't new, but have resurfaced in the wake of a Canadian study that some ...

Enjovo, a forward-thinking U.S.-based candy startup, is set to shake up the global confectionery industry with its unique approach to candy dispensing. The company has developed a patented ...

Children shouldn't receive the Moderna or Pfizer-BioNTech vaccines if they've had a severe allergic reaction to the ...

Novavax is a protein-based vaccine that contains a synthetic SARS-CoV-2 spike protein and Matrix-M adjuvant, which is an ingredient used to create a stronger immune response. Some inactivated vaccines ...

Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and ...

Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators ...